BSEOthers24 Aug 2026 · 24 Aug 2026, 05:46 pm

Meeting of the Board of Directors of the Company held today i.e., on Monday, 24th August, 2026, Board, inter-alia, considered the following: 1. Noting of resignation of Ms. Hasti Doshi ....

Eiko Lifesciences Ltd · 540204

✦ AI SummaryMgmt Change

Eiko Lifesciences Ltd announced the resignation of Ms. Hasti Doshi as Independent Director due to other career commitments, and the appointment of Mr. Suraj Mahadev Gaikwad as Additional Director (Independent and Non-Executive) to hold office up to the date of the ensuing Annual General Meeting, and thereafter as an Independent Director for a term of 5 years. The company also recommended the re-appointment of Mr. Bhavesh Dhirajlal Tanna as a Director, and convened the 49th Annual General Meeting for September 22, 2026.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Eiko Lifesciences Ltd - 540204 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday, 24Th August, 2026

Attachments (1)

📄

cc9cc461-95e0-4d68-ad56-c8600f883833.pdf

pdf

Download →
View document text
= EIKO LIFESCIENCES LIMITED M rfceEL THE CHEMISTRY Date: 24" August, 2026 Corporate Services Department, BSE Limited, Phiroze Jeejeebhoy Towers, 1st Floor, Dalal Street, Fort, Mumbai - 400001. Scrip Code: 540204 Subject: Outcome of the Board Meeting Dear Sir/Madam, Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), and amendments thereto, this is to inform that the Meeting of the Board of Directors of the Company held today i.e., on Monday, 24" August, 2026, Board, inter-alia, considered the following: 1. Noting of resignation of Ms. Hasti Doshi (DIN: 10757758) from the position of Independent Director with effect from closing of business hours of 24th August 2026 due to other career commitments. Details as required under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30" January 2026 is attached herewith as Annexure A 2. Approved appointment of Mr. Suraj Mahadev Gaikwad (DIN: 11159369) as Additional Director (Independent and Non-Executive) of the Company to hold the office up to the date of the ensuing Annual General Meeting of the Company, and thereafter as an Independent Director of the Company for a term of5 (five) years, subject to the approval of shareholders. Details as required under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30" January 2026 is attached herewith as Annexure B 3. Recommendation of Re-appointment of Mr. Bhavesh Dhirajlal Tanna (DIN: 03353445) as a “Director”, liable to retire by rotation, who has offered himself for re- appointment. 4. Convening Annual General Meeting (AGM) of the Members of the Company for the Financial Year 2025-26Th.e AGM will be held on Tuesday, 22" September, 2026 at 04:00 PM. The meeting will be held via Video Conferencing/Other Audio-Visual Means. 5. Approved Notice of 49th Annual General Meeting of the Members of the Company to be held on Tuesday, 22" September, 2026 at 04:00 pm through Video Conferencing/Other Audio-Visual Means. Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134 Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604 Mobile No.: +919082668855; Email id: investor.relations @eikolifesciences.com website: www.eikolifesciences.com = EIKO LIFESCIENCES LIMITED M rfceEL THE CHEMISTRY 6. Appointed Mr. Shravan Gupta (ACS: 27484, CP: 9990), proprietor of ShravaAn. Gupta & Associates, Company Secretary in Practice, as the Scrutinizer to scrutinize the E-Voting process (Remote E- Voting and E-Voting during the 49™ AGM) in a fair and transparent manner. 7. Appointment of M/s Bigshare Services Pvt Ltd. as the service provider for conducting the e-voting and video conferencifnogr the upcoming AGM. The Meeting commenced at 04:00 PM and concluded at 04:30 PM. Please take the same on your records. For Eiko Lifesciences Limited Chintan Doshi Company Secretary and Compliance Officer Membership No: A 36190 Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134 Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604 Mobile No.: +919082668855; Email id: investor.relations @eikolifesciences.com website: www.eikolifesciences.com = EIKO LIFESCIENCES LIMITED FEEL THE CHEMISTRY ANNEXURE — A Resignation of Ms. Hasti Doshi (DIN: 10757758) as Independent Director of the Company Details as required under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30th January 2026 are annexed herewith. Sr. No Particular Details 1. Reason for change viz. Ms. Hasti Doshi, acting as an Independent Director on appointment, Resignation, the Board of the Company decided to step down from retnoval-death-or-otherwise: her position as an Independent Director of the Company due to her other career commitments. The term of Ms. Hasti Doshi was supposed to be completed on 03 September, 2029, however she decided to focus on her career commitments and have tendered resignation from the Board with immediate effect. 2. Date of Resignation From the closure of business hours on 24" August, 2026 3. Qualification & brief profile (in case NA of appointment) 4. Disclosure of relationship between NA Directors (in case of appointment of Director) 5. Letter of Resignation along with Enclosed as - Annexure| detailed reason for Resignation 6. Names of listed entities in which NIL the resigning director holds directorships, indicating the category of directorship and membership of board committees, ifany Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134 Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604 Mobile No.: +919082668855; Email id: investor.relations @eikolifesciences.com website: www.eikolifesciences.com = EIKO LIFESCIENCES LIMITED FEEL THE CHEMISTRY ANNEXURE - B Brief details of Appointment of Mr. Suraj Mahadev Gaikwad (DIN: 11159369) as Additional Director (Independent and Non-Executive) Details as required under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30th January 2026 are annexed herewith. Sr. No Particular Details 1. Reason for change viz. Appointment of Mr. Suraj Mahadev Gaikwad as appointment, Resignation; Additional Independent and Non-Executive Director of removal, death-or otherwise; the Company. 2. Date of Appointment 24" August, 2026 3. Term of Appointment Appointment of Mr. Suraj Mahadev Gaikwad as Additional Director (Independent and Non-Executive) of the Company to hold the office up to the date of the ensuing Annual General Meeting of the Company, and thereafter as an Independent Director of the Company for a term of 5 (five) years, subject to the approval of shareholders. 4. Qualification & brief profile (in case Mr. Suraj Mahadev Gaikwad is Commerce Graduate, of appointment) having more than 7 years of experience in accountancy and business Management. He brings extensive knowledge and diverse expertise to his professional endeavors, contributing meaningfully to financial operations and strategic planning. His strong background in the accountancy sector positions him as a valuable asset in supporting the organization’s strategic goals and enhancing overall operational efficiency and compliance structure. 5. Disclosure of relationship between None Directors (in case of appointment of Director) 6. Affirmation as required pursuantto Mr. Suraj Mahadev Gaikwad is not debarred from BSE Circular with ref. no. holding the office of director on account of any order LIST/COMP/14/2018-19 dated 20t of SEBI or any other such authority June, 2018. Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134 Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604 Mobile No.: +919082668855; Email id: investor.relations @eikolifesciences.com website: www.eikolifesciences.com Annexure - I Date: 24th August, 2026 The Board of Directors Eiko Lifesciences Limited 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, . Wagle Estate, Thane, Maharashtra - 400604 Subject: Resignation from the position of Independent Director Dear Members, I, Ms. Hasti Doshi (DIN: 10757758), hereby tender my resignation from the position of Independent Director of the Company, with effect from the closing of business hours of 24th August, 2026. The reason for my resignation is on account of other career commitments that require my time and attention. T would like to place on record that I have no other reason for my resignation, and I confirm that there are no material reasons other than the one stated above. I would like to take this opportunity to thank the Board and the Company for the support and cooperation extended to me during my tenure as an Independent Director. I request the Board to kindly take my, resignation on record and take the necessary steps to inform the relevant regulatory authorities and update statutory records accor [Showing first 8,000 characters — download PDF for full document]